You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
綠康生化(002868.SZ):子公司參設的產業基金向紐瑞特醫療增資400萬元
格隆匯 01-22 16:13

格隆匯1月22日丨綠康生化(002868.SZ)公佈,公司於2018年2月6日召開的第二屆董事會第十六次(臨時)會議審議通過了《關於全資子公司參與投資設立產業基金的議案》,同意公司全資子公司綠康(平潭)投資有限公司(“綠康平潭”)擬使用人民幣4600萬元自有資金與隆裕弘達投資管理有限公司、福建華興創業投資有限公司、張露共同投資設立福建平潭華興康平醫藥產業投資合夥企業(有限合夥)(“產業基金”),並簽署基金合夥協議,綠康平潭為有限合夥人,該基金的管理人為福建省創新創業投資管理有限公司,投資基金將重點投向高成長性的、具備較高投資回報潛力的醫藥、醫療器械、醫療服務、大健康項目。

近日接到產業基金通知,產業基金與成都紐瑞特醫療科技股份有限公司(紐瑞特醫療”)簽署了增資協議並完成了投資。產業基金以人民幣400萬元增資紐瑞特醫療,投資完成後,產業基金佔紐瑞特醫療0.4793%的股權。

此次投資是公司參與設立的產業基金對外投資項目,屬於產業基金的正常投資經營行為,產業基金產生的投資收益可以為上市公司帶來新的利潤增長點,對公司無不利影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account